Cited by 105Tissue Engineering and Regenerative MedicinePluripotent Stem Cells ResearchMesenchymal stem cell research

Functional effects of a tissue-engineered cardiac patch from human induced pluripotent stem cell-derived cardiomyocytes in a rat infarct model

Open access
Wendel, Jacqueline S., Ye, Lei, Tao, Ran, Zhang, Jianyi, Zhang, Jianhua, Kamp, Timothy J., Tranquillo, Robert T.·2015·Stem Cells Translational Medicine

Abstract

A tissue-engineered cardiac patch provides a method to deliver cardiomyoctes to the injured myocardium with high cell retention and large, controlled infarct coverage, enhancing the ability of cells to limit remodeling after infarction. The patch environment can also yield increased survival. In the present study, we sought to assess the efficacy of a cardiac patch made from human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) to engraft and limit left ventricular (LV) remodeling acutely after infarction. Cardiac patches were created from hiPSC-CMs and human pericytes (PCs) entrapped in a fibrin gel and implanted acutely onto athymic rat hearts. hiPSC-CMs not only remained viable after in vivo culture, but also increased in number by as much as twofold, consistent with colocalization of human nuclear antigen, cardiac troponin T, and Ki-67 staining. CM+PC patches led to reduced infarct sizes compared with myocardial infarction-only controls at week 4, and CM+PC patch recipient hearts exhibited greater fractional shortening over all groups at both 1 and 4 weeks after transplantation. However, a decline occurred in fractional shortening for all groups over 4 weeks, and LV thinning was not mitigated. CM+PC patches became vascularized in vivo, and microvessels were more abundant in the host myocardium border zone, suggesting a paracrine mechanism for the improved cardiac function. PCs in a PC-only control patch did not survive 4 weeks in vivo. Our results indicate that cardiac patches containing hiPSC-CMs engraft onto acute infarcts, and the hiPSC-CMs survive, proliferate, and contribute to a reduction in infarct size and improvements in cardiac function. Significance: In the present study, a cardiac patch was created from human induced pluripotent stem cell-derived cardiomyocytes and human pericytes entrapped in a fibrin gel, and it was transplanted onto infarcted rat myocardium. It was found that a patch that contained both cardiomyocytes and pericytes survived transplantation and resulted in improved cardiac function and a reduced infarct size compared with controls.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.5966/sctm.2015-0044

Cites

40 of 40 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 3

  1. Zhang J, Wilson GF, Soerens AG et al. Func- tional cardiomyocytes derived from human in- duced pluripotent stem cells. Circ Res 2009; 104:e30-e41.
  2. Anderson D, Self T, Mellor IR et al. Trans- genic enrichment of cardiomyocytes from hu- man embryonic stem cells. Mol Ther 2007;15: 2027-2036.
  3. Armulik A, Genové G, Betsholtz C. Peri- cytes: Developmental, physiological, and path- ological perspectives, problems, and promises. Dev Cell 2011;21:193-215.

Cited by

Sorted by citations

Authors
Wendel, J. S., Ye, L., Tao, R., Zhang, J., Zhang, J., Kamp, T. J., & Tranquillo, R. T.
Affiliations
  • University of Minnesota (US)
  • University of Wisconsin–Madison (US)
Corresponding author
Tranquillo, Robert T.
Venue
Stem Cells Translational Medicine
Published
2015-09-14
Volume
4
Issue
11
Pages
1324-1332
ISSN
  • 2157-6564 (ISSN-L)
  • 2157-6580
OpenAlex
W2165811083
Cited by
105
References
40
Citations by year
2026: 3 · 2025: 4 · 2024: 3 · 2023: 8 · 2022: 11 · 2021: 14 · 2020: 14 · 2019: 12 · 2018: 10 · 2017: 15 · 2016: 9 · 2015: 2
FWCI
12.08
Type
journal article
Language
en
Open access
Locations
  • Stem Cells Translational Medicine (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Heart Research Institute
  • National Institutes of Health
  • National Heart, Lung, and Blood Institute (R01HL108670, HL95077, R01HL095077, U01HL100407)
  • National Institute of General Medical Sciences (T32GM113846)
Topics
  • Health Sciences › Medicine › Surgery › Tissue Engineering and Regenerative Medicine
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research
  • Health Sciences › Medicine › Genetics › Mesenchymal stem cell research
Keywords
iPSC-derived cardiomyocytes, myocardial infarction, left ventricular remodeling, infarct size reduction, fibrin gel, paracrine signaling, cardiac regeneration, cell proliferation, microvascularization
MeSH terms
Animals, Disease Models, Animal, Humans, Myocardial Infarction, Myocardium, Rats, Nude, Myocytes, Cardiac, Rats, Induced Pluripotent Stem Cells, Heterografts

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review